Puma Biotechnology-Puma Biotech (PBYI) Reports Q2 Loss, Tops Revenue Estimates

Puma Biotech (PBYI) came out with a quarterly loss of $0.05 per share versus the Zacks Consensus Estimate of a loss of$ 0.10. This compares to earnings of $0.10 per share a year ago. These figures are adjusted for nonrecurring items. This quarterly report represents an earnings surprise of 50%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of$ 0.16 per share when it actually produced a loss of $0.05, delivering a surprise of 68.75%. Over the last four quarters, the com ...